Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache

NCT05969119 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05969119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05969119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Completed
Start date
July 25, 2023
Completion date
January 3, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postdural puncture headache